We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+29.15%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$4.65B
AUM Growth
+$951M
Cap. Flow
+$238M
Cap. Flow %
5.12%
Top 10 Hldgs %
42.35%
Holding
109
New
44
Increased
20
Reduced
16
Closed
29

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$233M
2
OTIS icon
Otis Worldwide
OTIS
+$135M
3
RPRX icon
Royalty Pharma
RPRX
+$107M
4
BAX icon
Baxter International
BAX
+$105M
5
FIVE icon
Five Below
FIVE
+$104M

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$226M
2
BSX icon
Boston Scientific
BSX
+$147M
3
JNJ icon
Johnson & Johnson
JNJ
+$121M
4
FIS icon
Fidelity National Information Services
FIS
+$99.8M
5
AMZN icon
Amazon
AMZN
+$68.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.01%
2 Technology 20.81%
3 Industrials 20.34%
4 Consumer Discretionary 17.45%
5 Communication Services 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSC icon
26
Norfolk Southern
NSC
$76.9B
$70.3M 1.51%
400,587
-142,393
-26% -$24.1M
ROK icon
27
Rockwell Automation
ROK
$49.2B
$67.1M 1.44%
+314,810
New +$60.9M
LH icon
28
Labcorp
LH
$25.6B
$66.1M 1.42%
+463,319
New +$64.1M
NKE icon
29
Nike
NKE
$62.3B
$65.2M 1.4%
665,300
-319,323
-32% -$29.5M
DHI icon
30
D.R. Horton
DHI
$40.8B
$65M 1.4%
+1,171,548
New +$56.8M
LHX icon
31
L3Harris
LHX
$53.9B
$63.8M 1.37%
376,082
+14,851
+4% +$2.79M
GAP
32
The Gap Inc
GAP
$7.39B
$63.1M 1.36%
+5,000,000
New +$45M
HUM icon
33
Humana
HUM
$44.1B
$61.7M 1.33%
+159,210
New +$59.6M
CVNA icon
34
Carvana
CVNA
$75.1B
$59.5M 1.28%
+2,475,100
New +$46.4M
GFL icon
35
GFL Environmental
GFL
$15B
$58.9M 1.27%
3,137,780
+250,440
+9% +$4.28M
HOLX
36
DELISTED
Hologic
HOLX
$53.6M 1.15%
+941,054
New +$46.2M
PLAN
37
DELISTED
Anaplan, Inc.
PLAN
$51.4M 1.1%
1,133,304
-90,868
-7% -$3.8M
CTLT
38
DELISTED
CATALENT, INC.
CTLT
$49.6M 1.06%
+676,100
New +$45.9M
ROST icon
39
Ross Stores
ROST
$81.6B
$44.1M 0.95%
517,584
-17,186
-3% -$1.56M
DGX icon
40
Quest Diagnostics
DGX
$26.3B
$40.8M 0.88%
+357,835
New +$38M
CSGP icon
41
CoStar Group
CSGP
$12B
$32.6M 0.7%
+459,000
New +$29.7M
WPF.U
42
DELISTED
Foley Trasimene Acquisition Corp.
WPF.U
$29.2M 0.63%
+2,732,300
New +$28.6M
CLOV icon
43
Clover Health Investments
CLOV
$2.45B
$28.3M 0.61%
+2,532,593
New +$27.2M
INSM icon
44
Insmed
INSM
$28.7B
$24.7M 0.53%
895,560
+828,960
+1,245% +$19.7M
HYLN icon
45
Hyliion Holdings
HYLN
$704M
$24.4M 0.52%
+890,000
New +$10.8M
JWS.U
46
DELISTED
Jaws Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one red
JWS.U
$21.1M 0.45%
+2,023,700
New +$21.1M
BMY.RT
47
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$17M 0.37%
4,761,119
+241,409
+5% +$871K
BSX icon
48
Boston Scientific
BSX
$71.4B
$16M 0.34%
455,000
-4,089,220
-90% -$147M
OPEN icon
49
Opendoor
OPEN
$3.34B
$14.3M 0.31%
+1,254,467
New +$13.8M
TREB.U
50
DELISTED
Trebia Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third of one
TREB.U
$13.8M 0.3%
+1,316,000
New +$13.7M
1
2
3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return

Suvretta Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Suvretta Capital Management held 109 positions worth $4.65B, up 26% from $3.7B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Suvretta Capital Management deployed $238M of net new capital in Q2 2020, opening 44 new positions and adding to 20 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,114,740 shares worth $253M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Boston Scientific, an estimated $147M trimmed.

  • Suvretta Capital Management's largest Q2 2020 buy was Meta Platforms (Facebook): 1,114,740 shares worth $253M.
  • Suvretta Capital Management added most to Uber in Q2 2020, an estimated $82.8M increase.
  • Suvretta Capital Management's biggest Q2 2020 reduction was Boston Scientific, cutting an estimated $147M.
  • Suvretta Capital Management fully exited Salesforce in Q2 2020, selling an estimated $226M.
  • Suvretta Capital Management's ten largest holdings make up 42% of its $4.65B portfolio in Q2 2020.
  • Suvretta Capital Management opened 44 new positions and closed 29 in Q2 2020.
  • Suvretta Capital Management's portfolio value rose 26% quarter-over-quarter to $4.65B.

Based on Suvretta Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.